What drove PATH stock higher on 12 Jan 2026?

PATH stock rose to **$17.24** on 12 Jan 2026 after intraday strength tied to positive sentiment around UiPath’s AI roadmap and product upsells, with volume of **18,595,451** shares compared with a 30‑day average of **24,152,591**.

What is Meyka AI’s grade for PATH stock and what does it mean?

Meyka AI rates PATH with a score out of 100: **75.25** (Grade **B+**, Suggestion: **BUY**). The grade balances S&P 500 and sector comparisons, financial growth, key metrics, forecasts, and analyst consensus.

What price targets or forecasts exist for PATH stock?

Meyka AI’s forecast model projects monthly **$18.90**, quarterly **$17.92**, and yearly **$16.65**. The monthly figure implies a **9.63%** upside from the current **$17.24**; forecasts are projections, not guarantees.

What are the main risks for PATH stock investors?

Main risks for PATH stock include execution on AI product rollouts, softer enterprise IT budgets, and valuation compression given a trailing P/E of **41.04**. Weak adoption could pressure revenue and multiples.

US Stocks

PATH UiPath Inc. (NYSE) closed $17.24 on 12 Jan 2026: AI roadmap key test

ByDanny Kontos January 13, 2026January 13, 2026

UiPath (PATH) closed at $17.24 on 12 Jan 2026 after a +5.64% intraday move, keeping the AI automation story in focus. PATH stock climbed from an open of $16.58 and traded between $16.34 and $17.36. Volume reached 18,595,451 shares versus a 30‑day average of 24,152,591, showing lighter-than-average participation. Investors are weighing the company’s AI roadmap and Maestro platform upsells against a P/E of 41.04 and a market cap of $9.22B in the United States market (NYSE, USD).